newsfilter
← Latest News
GlobeNewswire·

Enlivex Treasury Portfolio Update: New Listing of the RAIN Token on Kraken, the Second-Largest U.S. Cryptocurrency Exchange

  • Enlivex Therapeutics Ltd. announced that its primary treasury asset, the RAIN token, was listed on the Kraken cryptocurrency exchange effective February 9, 2026.
  • Kraken is the second-largest U.S.-based cryptocurrency exchange with 5.7 million users & a 2025 total trading volume exceeding $2 trillion.
  • The listing aims to increase liquidity, improve price discovery, & enhance accessibility for participants in the RAIN ecosystem.
  • RAIN serves as the governance & utility token for a decentralized predictions & options protocol built on the Arbitrum network.
  • Enlivex is the first publicly-listed company to center its treasury strategy on RAIN as its primary reserve asset.
  • Enlivex is a clinical-stage company developing Allocetra™, a therapy for osteoarthritis, which affects over 32.5 million Americans & 300 million people globally.
  • No medications currently approved by the FDA or EMA have been demonstrated to arrest, slow, or reverse structural joint damage from osteoarthritis.
  • The press release includes forward-looking statements regarding anticipated benefits of the exchange listing & clinical trial outcomes.
  • Risks cited include the volatile nature of cryptocurrency prices, regulatory uncertainty, & potential correlation between RAIN liquidity & Enlivex stock performance.